-
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Average Rating of "Buy" by Brokerages
Source: Buzz FX / 28 Jan 2025 02:26:19 America/New_York
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Average Rating of "Buy" by Brokerages Written by MarketBeat January 28, 2025 Share Link copied to clipboard. Shares of Crinetics Pharmaceuticals, Inc.
Read more...